Correction to “Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘ eCGM ’ compliance status”

Read full text
Cited by: 0

Abstract

Mathieu C, Irace C, Wilmot EG, et al. Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘eCGM’ compliance status. Diabetes Obes Metab. 2025;27(3):1025-1031. doi:10.1111/dom.16153 In Table 1, the final two rows indicating the proposed minimum performance for regulatory approval for CGM devices in Europe contained two typographical errors that made the requirements for CGM reporting of rates of change in interstitial glucose incorrect. These errors do not compromise the overall understanding and interpretation of the proposed minimum performance requirements. The corrected table is shown here. The original article has been corrected. We apologize for this error.

Fields of Study & Subjects

Diabetes Management and Research Diabetes Treatment and Management Healthcare Regulation

Publication details

Journal / source
Diabetes Obesity and Metabolism
Volume
28
Issue
4
Pages
3452–3452
Publication date
28 January 2026
Language
EN